CRISPR Therapeutics AG reported cash from operations of -$89.68M and free cash flow of -$90.10M for the quarter ended Sep 2026. This cash flow statement covers 45 quarters of results from Sep 2015 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
Pull CRISPR Therapeutics AG's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CRSP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CRSP", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CRSP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();